IMPACT OF MULTIDRUG-RESISTANT BACTERIA INFECTIONS ON TREATMENT OUTCOMES IN PATIENTS WITH SEVERE BURNS

Nhu Lam Nguyen1,2, Quoc Vuong Le1,2, , Duc Man Le1,2, Tuan Hung Ngo1,2
1 Bộ môn Bỏng và Y học Thảm họa, Học viện Quân y
2 Bệnh viện Bỏng Quốc gia Lê Hữu Trác, Học viện Quân y

Main Article Content

Abstract

Objectives: To evaluate the impact of multidrug-resistant bacterial (MDRb)  infections on mortality rate, superficial wound healing time, and treatment costs among patients with severe burns. Methods: A prospective, descriptive, longitudinal study was conducted on 131 severe burn patients treated at the Intensive Care Unit (ICU), National Burn Hospital Le Huu Trac, from January 2023 to December 2023. A total of 744 clinical specimens (blood, wound exudate, and urine) were analyzed. Results: Deep burn surface area and MDRb bloodstream infections were independently associated with mortality (p < 0.05). Each 1% increase in deep burn area was associated with a 1.07-fold increase in mortality risk, while the presence of MDRb in blood increased the risk 8.03-fold after adjustment for other factors. MDRb bloodstream infection showed moderate prognostic value for mortality (AUC = 0.75), with a sensitivity of 55.77% and a specificity of 93.67%. Patients with MDRb infection had significantly longer ICU stays, prolonged superficial wound healing, and higher treatment costs per 1% total burn surface area compared to those without MDR infections (p < 0.01). Conclusion: MDRb infections significantly increase mortality, prolong wound healing time, and elevate treatment costs in severe burn patients (p < 0.05). MDRb-positive blood cultures are an independent prognostic factor for mortality (p < 0.01).

Article Details

References

1. Soedjana H, Nadia J, Sundoro A, et al. The profile of severe burn injury patients with sepsis in hasan sadikin bandung general hospital. Annals of Burns and Fire Disasters. 2020; 33(4):312.
2. Martina NR, Wardhana A. Mortality analysis of adult burn patients. Journal Plastik Rekonstruksi. 2013; 2(2):96-100.
3. Tchakal-Mesbahi A, Abdouni M, Metref M. Prevalence of multidrug-resistant bacteria isolated from burn wounds in algeria. Annals of Burns and Fire Disasters. 2021; 34(2):150.
4. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection. 2012; 18(3):268-281.
5. Branski LK, Al-Mousawi A, Rivero H, et al. Emerging infections in burns. Surgical Infections. 2009, 10(5):389-397.
6. Gallaher JR, Banda W, Lachiewicz AM, et al. Colonization with multidrug-resistant Enterobacteriaceae is associated with increased mortality following burn injury in sub-Saharan Africa. World Journal of Surgery; 2018; 42:3089-3096.
7. Veronica RM, Nelwan EJ, Kumalawati J, et al. The effect of multidrug-resistant organism infection on mortality of burn patients at RSUPN Dr. Cipto Mangunkusumo. Annals of Burns and Fire Disasters. 2024; 37(2):159-168.
8. Cleland H, Tracy LM, Padiglione A, et al. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: A retrospective review. Antimicrobial Resistance & Infection Control. 2022; 11(1):82.